Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
ABCD3	"PMP70, PXMP1, ZWS2"	ENSG00000117528	"ATP binding cassette subfamily D member 3"	P28288	1	94418455-94518666	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032026, HPA032027, CAB032516, CAB075749"	Enhanced		Enhanced	Peroxisomes				Peroxisomes		"CAB032516: AB_2257637, CAB075749: , HPA032026: AB_2674117, HPA032027: AB_10602103"	"unprognostic (1.41e-2)"	"unprognostic (3.21e-1)"	"prognostic favourable (1.16e-5)"	"unprognostic (1.92e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.12e-2)"	"prognostic favourable (4.84e-5)"	"unprognostic (5.45e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	8.9	14.2	13.1	9.5	13.3	10.3	16.8	11.2	12.8	11.8	21.2	14.9	24.9	21.4	9.8	14.6	15.4	10.0	17.3	16.0	12.7	10.3	29.3	60.6	11.2	9.9	13.2	10.4	8.1	16.7	18.3	14.6	11.2	14.3	11.0	20.1	21.4	13.2	24.0	12.9	17.1	21.7	10.8	16.5	7.6	20.8	10.2	12.7	46.5	13.7	10.8	9.9	11.8	11.1	3.1	8.4	3.9	6.2	8.0	7.4	4.2	27.7	13.0	13.5	12.8	10.4	11.5	20.0	14.5	11.3	16.7	18.6	40.6	8.8	17.2	18.8	18.3	20.4	15.5	18.8	23.5	13.8	13.4	19.5	19.3	35.2	10.1	17.3	6.0	9.6	10.6	19.4	7.5	10.2	8.7	10.4	17.2	3.9	29.0	9.1	15.5	18.6	16.4	28.1	6.6	16.5	42.5	10.2	16.8	25.1	26.7	18.9	9.8	14.4	10.1	12.5	18.0	21.8	19.2	5.9	5.4	16.8	9.7	8.9	5.8	0.3	5.3	3.9	6.5	6.2	6.1	2.8	5.9	7.4	8.4	3.1	7.1	6.9	1.3	8.0	5.2	2.2	6.5	4.2	13.1	13.3	11.2	12.8	12.7	10.3	13.2	10.4	14.3	12.7
ACAA1		ENSG00000060971	"Acetyl-CoA acyltransferase 1"	P09110	3	38103129-38137242	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006764, HPA007244"	Enhanced		Enhanced	Peroxisomes			4300000	Peroxisomes		"HPA006764: AB_1078085, HPA007244: AB_1078084"	"prognostic favourable (3.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (4.54e-2)"	"prognostic favourable (7.53e-4)"	"unprognostic (2.63e-1)"	"prognostic favourable (1.23e-4)"	"unprognostic (9.35e-3)"	"unprognostic (2.91e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.90e-1)"	"prognostic favourable (6.99e-9)"	"unprognostic (1.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.65e-2)"	9.5	12.7	11.0	5.6	11.9	9.6	10.2	8.1	14.3	6.7	16.1	12.5	10.6	23.4	4.9	13.3	12.1	4.6	16.0	17.7	10.2	8.9	48.7	152.1	8.2	5.9	14.0	9.4	5.0	19.2	7.4	5.9	6.8	11.0	13.4	12.4	7.3	11.5	9.4	9.8	6.2	23.8	4.8	12.7	10.0	8.5	4.4	10.9	5.7	9.3	10.1	10.2	9.4	7.0	9.2	47.0	32.8	45.2	17.8	19.3	18.8	8.4	9.2	3.1	9.9	13.6	7.9	10.9	7.8	11.3	8.9	8.5	12.3	9.5	5.0	5.6	12.4	5.6	8.5	13.1	4.9	7.3	8.8	6.5	8.1	34.8	8.8	14.8	14.5	14.7	9.4	7.6	5.5	12.0	6.0	5.9	9.9	11.0	14.3	10.6	3.3	11.2	3.3	6.0	8.4	25.1	25.1	2.7	4.2	7.6	85.3	5.4	8.8	11.9	8.7	5.4	5.2	10.7	10.6	7.8	5.0	3.9	8.8	12.9	8.5	15.3	29.9	32.8	13.6	40.7	11.4	9.2	13.1	13.3	47.0	8.7	13.0	12.1	20.4	17.8	45.2	27.7	19.3	18.8	11.0	11.9	8.1	14.3	10.2	8.9	14.0	9.4	11.0	10.9
ACBD5	"DKFZp434A2417, KIAA1996"	ENSG00000107897	"Acyl-CoA binding domain containing 5"	Q5T8D3	10	27195214-27242130	"Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011861, HPA012145"	Enhanced		Enhanced	Peroxisomes				Peroxisomes		"HPA011861: AB_1844493, HPA012145: AB_1844494"	"prognostic unfavourable (3.33e-4)"	"unprognostic (4.93e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.98e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.46e-2)"	"prognostic favourable (4.68e-5)"	"unprognostic (7.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.37e-3)"	9.2	15.7	25.7	7.1	21.5	7.7	7.4	13.7	21.3	8.4	15.5	17.7	9.1	23.0	5.6	6.1	7.2	7.4	9.0	23.0	23.0	21.1	22.8	44.7	8.5	7.6	27.4	14.0	6.3	6.5	18.9	6.0	7.8	21.3	9.2	12.6	12.9	7.2	10.2	15.8	9.3	24.6	5.3	31.0	8.4	12.2	10.8	20.9	5.7	16.6	7.6	7.6	9.7	5.8	7.0	12.9	11.5	14.0	9.0	16.6	7.4	12.2	37.5	8.1	9.0	9.8	9.0	10.2	15.4	6.2	14.1	17.1	9.3	19.4	5.5	13.6	10.9	10.0	12.0	8.1	12.1	12.5	11.8	7.6	11.2	7.1	11.4	4.9	10.3	8.7	9.0	11.8	6.8	10.3	6.3	8.4	18.3	9.3	10.1	4.1	6.4	4.8	8.7	21.3	9.5	22.7	11.0	11.5	22.8	17.4	19.1	9.0	9.3	5.6	14.5	13.8	7.6	21.5	12.4	9.8	13.4	9.9	13.9	12.1	5.9	9.4	13.1	10.5	16.6	12.9	16.4	7.0	8.3	13.0	12.9	7.0	5.7	12.0	11.5	9.0	14.0	9.3	7.3	7.4	25.7	21.5	13.7	19.2	23.0	21.1	27.4	14.0	21.3	20.9
ACOX1	PALMCOX	ENSG00000161533	"Acyl-CoA oxidase 1"	Q15067	17	75941507-75979363	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 95.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 34.6;RT4: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 22.9;neutrophil: 38.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021094, HPA021192, HPA021195, HPA028759"	Approved		Approved	Nucleoli,Peroxisomes			160000	Peroxisomes	Nucleoli	"CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352"	"unprognostic (7.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.38e-2)"	"prognostic favourable (5.25e-7)"	"unprognostic (3.39e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.46e-2)"	21.8	12.9	8.8	8.3	10.2	4.2	13.6	6.4	9.8	6.4	26.5	8.2	9.6	31.0	6.6	6.7	19.5	6.0	12.3	16.0	8.3	7.9	20.8	95.6	9.2	7.5	8.2	8.3	7.6	28.7	9.8	8.9	13.6	7.8	9.5	14.3	11.3	9.5	9.1	18.3	13.4	53.1	7.9	6.7	7.2	13.6	6.2	6.3	7.1	9.1	11.4	10.6	10.6	7.9	1.6	3.3	38.6	5.8	2.1	2.7	2.2	5.3	7.6	2.5	3.8	13.0	5.5	34.6	3.9	3.9	4.7	5.4	5.3	8.8	3.1	4.2	6.6	3.2	10.5	4.1	7.4	2.8	3.1	4.0	4.3	17.3	7.1	3.4	2.6	9.1	3.2	5.3	3.5	11.7	4.0	3.0	5.2	15.7	7.4	2.5	1.8	6.5	4.1	7.6	3.6	8.0	46.6	3.0	4.5	11.1	17.5	3.7	10.7	3.8	7.8	6.5	4.8	5.3	3.7	5.0	3.4	1.2	3.8	3.1	3.8	22.9	5.8	1.6	2.1	4.5	2.7	1.6	2.0	2.7	3.3	1.6	2.4	2.3	38.6	2.1	2.8	2.9	2.6	2.2	8.8	10.2	6.4	9.8	8.3	7.9	8.2	8.3	7.8	6.3
ACOX3		ENSG00000087008	"Acyl-CoA oxidase 3, pristanoyl"	O15254	4	8366282-8440723	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035840, HPA035841"	Uncertain		Approved	Peroxisomes				Peroxisomes		"HPA035840: AB_10696514, HPA035841: AB_10671940"	"unprognostic (3.07e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.12e-1)"	"prognostic favourable (2.16e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (4.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.65e-1)"	9.6	12.0	9.9	7.4	10.9	5.0	15.5	11.7	12.8	12.2	9.9	11.5	11.2	10.8	10.7	12.3	32.0	9.2	7.4	20.6	9.0	6.7	8.3	18.0	8.9	7.4	10.3	8.4	9.8	15.4	10.0	14.8	28.9	10.2	13.4	8.0	12.0	19.1	11.2	8.2	14.8	10.5	18.6	7.2	7.6	12.7	5.0	11.6	9.0	11.5	7.4	14.2	14.8	16.0	4.6	16.8	2.6	12.0	7.3	8.0	6.9	6.3	6.9	7.8	10.4	8.4	14.3	12.8	8.1	11.1	13.8	12.1	3.4	8.5	8.5	8.8	16.4	3.9	3.4	10.5	10.8	2.9	3.3	3.7	5.8	10.5	13.9	7.5	7.0	14.4	9.0	12.3	4.8	16.2	4.9	7.9	11.8	5.8	8.0	11.1	4.4	12.0	8.4	12.8	10.2	8.5	8.9	3.8	8.8	10.3	5.3	5.3	5.3	10.7	15.7	13.7	4.5	5.5	8.4	5.9	3.9	3.8	17.4	9.5	8.6	0.0	10.6	2.6	5.2	12.0	5.4	4.6	6.1	6.6	14.0	4.5	5.6	5.8	2.5	7.3	10.6	16.8	8.0	6.9	9.9	10.9	11.7	12.8	9.0	6.7	10.3	8.4	10.2	11.6
AGPS	"ADAP-S, ADAS, ADHAPS, ADPS, ALDHPSY"	ENSG00000018510	"Alkylglycerone phosphate synthase"	O00116	2	177392644-177559299	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cataract, Disease mutation, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030209, HPA030210, HPA030211"	Supported		Enhanced	Peroxisomes	"Intracellular and membrane"		9300	Peroxisomes		"HPA030209: AB_10600634, HPA030210: AB_10600202, HPA030211: AB_10602195"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.78e-2)"	"prognostic unfavourable (8.62e-6)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.41e-2)"	"prognostic unfavourable (8.35e-4)"	"unprognostic (7.74e-2)"	"prognostic favourable (9.45e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.92e-2)"	22.9	17.7	13.5	21.2	14.9	28.3	17.1	14.9	13.4	16.0	23.5	17.2	14.1	14.1	22.4	10.5	18.4	12.5	16.0	23.9	14.2	13.5	20.8	21.2	15.2	14.7	17.4	11.8	16.4	21.2	37.0	11.7	14.7	15.0	14.7	24.0	8.0	18.2	10.8	23.2	9.6	17.6	21.3	31.8	17.1	14.5	19.1	13.7	29.5	14.2	14.4	14.5	16.9	20.7	3.4	7.6	11.2	6.8	5.6	6.4	3.0	17.7	11.4	8.1	8.3	10.4	11.4	19.3	13.9	6.9	11.9	11.8	21.2	12.4	20.0	30.4	14.4	19.4	21.8	14.2	15.6	26.4	7.4	27.8	19.8	24.9	10.6	30.1	29.6	9.9	9.0	19.1	15.2	23.8	19.0	12.5	14.3	0.0	24.3	10.2	13.8	18.9	19.5	24.2	12.1	20.3	21.3	10.0	12.1	26.4	2.3	16.4	0.1	12.5	24.4	10.7	36.7	10.9	24.3	16.2	28.0	10.0	9.8	13.5	4.1	3.8	6.1	11.2	4.3	6.7	6.4	3.4	5.5	5.3	7.6	2.1	5.3	3.1	1.3	5.6	6.8	0.7	6.2	3.0	13.5	14.9	14.9	13.4	14.2	13.5	17.4	11.8	15.0	13.7
DECR2	"PDCR, SDR17C1"	ENSG00000242612	"2,4-dienoyl-CoA reductase 2"	Q9NUI1	16	401826-412487	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 68.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047631			Approved	Peroxisomes				Peroxisomes		"HPA047631: "	"unprognostic (2.74e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.22e-3)"	5.7	10.8	3.2	4.3	4.0	3.5	4.0	3.8	5.0	2.9	10.2	2.7	5.0	14.2	4.0	7.3	4.1	2.5	7.8	4.4	2.8	2.3	16.9	68.2	4.3	3.9	2.0	3.0	2.6	9.7	1.8	2.6	2.3	2.0	4.1	2.4	3.0	6.2	5.6	15.9	2.9	14.4	5.1	1.9	1.9	5.9	4.1	1.8	1.2	1.7	4.3	2.9	2.7	2.2	3.3	9.5	0.4	6.1	2.7	5.1	3.9	1.1	10.9	1.4	6.5	1.2	3.0	4.1	3.3	2.5	2.8	3.0	6.9	7.5	3.7	7.2	4.1	2.5	1.1	2.8	0.4	8.3	3.5	0.9	5.3	16.4	8.6	3.3	5.3	4.2	2.1	1.9	2.4	3.6	2.3	3.4	2.4	11.4	1.9	4.6	4.1	5.7	4.5	0.5	6.8	2.8	2.9	2.9	4.4	6.3	7.1	3.7	10.2	4.2	7.4	2.4	2.7	3.4	2.5	4.9	3.9	1.6	3.4	5.0	8.0	0.0	6.1	0.4	3.6	5.6	2.5	2.8	2.2	2.4	6.5	3.3	5.1	3.0	0.3	2.7	4.5	9.5	1.7	3.9	3.2	4.0	3.8	5.0	2.8	2.3	2.0	3.0	2.0	1.8
ECI2	"ACBD2, DRS1, HCA88, PECI"	ENSG00000198721	"Enoyl-CoA delta isomerase 2"	O75521	6	4115689-4135597	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 102.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA022130, HPA031626"	Enhanced		Enhanced	Peroxisomes,Mitochondria				"Peroxisomes, Mitochondria"		"HPA022130: AB_1855176, HPA031626: AB_2673965"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.75e-2)"	"prognostic favourable (2.04e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.34e-1)"	17.9	29.2	13.2	7.3	17.4	4.5	17.0	8.9	9.5	15.7	18.0	10.7	14.9	16.2	15.2	26.2	10.6	12.7	12.4	32.1	10.3	11.1	56.8	102.3	7.4	8.9	13.3	7.2	19.0	59.2	8.9	17.2	11.1	10.3	14.6	14.0	13.3	9.0	10.5	45.7	5.6	22.7	10.3	11.9	10.1	23.2	11.9	9.3	13.3	17.7	26.6	7.5	12.6	8.9	20.6	25.1	7.0	16.2	25.5	27.7	16.7	17.8	9.7	16.3	35.4	20.5	30.5	2.0	25.3	26.0	27.7	24.8	7.3	2.7	0.7	31.9	27.5	9.4	18.5	14.7	40.3	6.7	21.2	9.4	13.8	39.3	11.9	8.5	4.7	21.0	9.1	23.5	13.2	57.6	30.8	6.9	26.2	7.1	24.0	21.2	11.0	34.9	23.3	20.2	0.3	14.9	3.6	0.3	7.6	1.5	10.6	22.4	24.5	4.0	58.1	20.9	11.5	18.4	15.0	10.6	18.8	1.8	10.7	7.5	16.1	6.9	15.5	7.0	18.9	11.5	25.9	19.9	22.3	26.4	25.1	20.6	27.7	27.1	0.4	25.5	16.2	19.2	23.6	16.7	13.2	17.4	8.9	9.5	10.3	11.1	13.3	7.2	10.3	9.3
FAR1	"FLJ22728, MLSTD2, SDR10E1"	ENSG00000197601	"Fatty acyl-CoA reductase 1"	Q8WVX9	11	13668670-13732346	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Cataract, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017322	Approved		Supported	Peroxisomes				Peroxisomes		"HPA017322: AB_1848424"	"unprognostic (3.96e-2)"	"unprognostic (1.92e-1)"	"prognostic favourable (2.27e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-3)"	16.3	11.1	19.0	14.2	28.2	42.7	13.7	24.4	24.0	17.3	20.9	33.8	11.1	24.7	17.4	17.1	38.1	12.7	9.2	13.9	20.4	16.1	9.7	3.3	13.9	12.2	32.8	24.0	16.7	15.8	25.1	16.5	15.8	30.0	14.1	25.1	10.0	14.6	10.9	11.4	8.0	13.4	20.2	47.8	13.9	39.4	12.8	32.2	13.2	13.2	17.2	15.0	16.7	22.1	2.8	15.8	21.8	13.7	5.0	4.5	4.0	26.9	17.6	17.5	13.6	16.7	19.3	9.5	24.2	9.7	17.9	19.0	18.5	23.3	34.7	10.8	19.2	29.5	25.7	24.4	27.5	10.2	20.9	14.8	16.1	0.1	16.1	29.7	12.0	14.6	25.2	12.9	38.8	17.4	23.1	10.4	14.6	13.6	22.0	8.9	9.1	25.6	19.4	22.3	9.7	17.3	43.9	13.5	9.8	22.9	21.8	11.8	13.4	18.6	21.6	24.7	21.1	22.6	20.1	5.8	19.7	29.5	15.7	9.1	14.9	4.6	13.7	15.0	4.5	11.9	3.1	2.1	2.2	3.8	15.8	2.8	2.0	3.4	21.8	5.0	9.4	2.4	2.8	4.0	19.0	28.2	24.4	24.0	20.4	16.1	32.8	24.0	30.0	32.2
GSTK1	GST13	ENSG00000197448	"Glutathione S-transferase kappa 1"	Q9Y2Q3	7	143244093-143270854	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006311, HPA022904"	Supported		Supported	Peroxisomes			1300000	Peroxisomes		"HPA006311: AB_1849786, HPA022904: AB_1849787"	"prognostic favourable (4.41e-6)"	"unprognostic (2.40e-1)"	"unprognostic (6.53e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.99e-2)"	"unprognostic (7.27e-2)"	"prognostic favourable (2.10e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.15e-2)"	38.0	45.3	14.0	45.3	19.9	29.0	43.0	5.6	19.6	30.4	69.0	19.9	35.7	58.0	24.8	39.8	37.8	27.4	55.2	56.4	15.0	13.1	67.6	97.1	35.4	52.2	24.3	16.3	22.7	39.9	46.2	20.7	41.5	23.9	28.0	43.5	34.4	72.9	35.8	38.9	30.0	91.0	22.2	17.5	58.5	34.8	18.9	20.8	27.1	48.0	56.6	50.3	29.4	26.6	32.8	57.1	35.7	75.4	22.3	99.0	95.2	27.1	19.6	2.7	24.4	43.3	62.2	13.0	16.1	27.6	14.4	28.8	11.8	69.8	15.5	23.0	23.2	41.2	10.7	25.2	12.6	29.8	11.6	12.6	14.7	18.5	29.8	15.2	20.6	56.1	31.0	16.6	11.8	38.2	17.6	18.9	38.5	20.9	15.5	27.6	6.5	29.7	13.4	0.4	30.6	49.9	15.0	11.3	15.4	29.5	48.1	24.4	23.1	21.3	22.5	7.8	7.3	20.5	13.6	32.4	15.2	3.5	28.3	61.3	16.1	35.7	67.9	25.8	41.1	74.8	39.6	32.8	76.4	52.4	57.1	21.9	39.5	38.1	21.2	22.3	75.4	23.9	99.0	95.2	14.0	19.9	5.6	19.6	15.0	13.1	24.3	16.3	23.9	20.8
HSD17B4	"DBP, MFE-2, SDR8C1"	ENSG00000133835	"Hydroxysteroid 17-beta dehydrogenase 4"	P51659	5	119452443-119637199	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Oxidoreductase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021302, HPA021311, HPA021479"	Enhanced		Enhanced	Peroxisomes			6900000	Peroxisomes		"HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (1.33e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"prognostic favourable (6.31e-6)"	"unprognostic (1.60e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-3)"	25.1	42.4	22.1	15.5	21.3	6.4	46.0	12.3	23.6	27.8	30.1	24.1	83.8	28.6	16.2	20.7	24.6	15.1	20.6	27.3	23.8	21.2	31.3	116.3	30.5	16.7	27.0	21.7	15.1	29.9	33.2	20.5	19.0	23.9	20.9	25.2	10.7	20.0	86.2	20.7	19.2	30.5	15.6	33.6	16.9	20.7	8.1	25.5	10.8	48.9	17.3	14.5	24.1	25.3	6.1	11.1	31.4	13.6	3.2	4.2	5.3	17.7	15.3	28.8	38.1	71.9	33.8	15.2	17.3	23.3	16.4	29.9	12.6	29.5	23.7	35.6	18.7	17.8	21.1	37.6	25.6	25.9	19.5	31.2	16.6	24.1	18.3	9.8	48.9	29.4	15.8	17.6	16.5	28.0	10.6	13.8	17.8	15.4	15.0	6.4	21.3	10.8	19.2	28.8	25.6	26.2	49.0	21.7	18.7	40.6	6.4	18.9	23.6	16.6	19.9	16.1	11.0	17.7	14.1	7.0	14.7	8.7	18.3	26.3	15.8	31.4	13.6	24.7	3.4	8.0	4.2	6.1	3.2	2.9	11.1	5.8	3.1	2.9	2.4	3.2	7.8	6.9	2.0	5.3	22.1	21.3	12.3	23.6	23.8	21.2	27.0	21.7	23.9	25.5
PECR	"HSA250303, SDR29C1, TERP"	ENSG00000115425	"Peroxisomal trans-2-enoyl-CoA reductase"	Q9BY49	2	215996329-216082955	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 78.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 24.2;RPTEC TERT1: 23.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 30.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021593, HPA022539"	Enhanced		Supported	Peroxisomes				Peroxisomes		"HPA021593: AB_1855177, HPA022539: AB_1855178"	"unprognostic (7.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.16e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.01e-3)"	"unprognostic (5.61e-2)"	"prognostic favourable (1.36e-5)"	"unprognostic (6.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.75e-2)"	"unprognostic (6.64e-2)"	14.2	4.4	3.2	6.5	3.3	3.5	7.0	6.7	3.7	2.8	11.5	4.4	2.7	13.2	2.0	6.6	2.4	4.5	7.2	2.7	3.3	3.1	17.4	78.4	3.6	3.8	4.4	2.9	3.2	3.1	3.8	5.4	0.9	3.5	3.1	4.2	6.2	3.5	3.5	3.4	3.3	20.9	3.2	5.1	2.8	2.6	0.9	3.6	2.4	8.5	2.0	3.5	2.2	4.1	5.1	1.4	4.1	3.9	8.8	14.7	4.1	3.8	4.2	1.7	0.1	10.4	3.9	2.1	0.9	2.1	2.5	4.1	4.8	11.0	0.1	7.9	2.2	0.9	4.7	5.6	4.3	6.0	5.0	4.9	2.4	24.2	10.5	1.3	3.4	3.3	3.9	2.5	3.6	2.4	2.0	5.6	5.3	2.7	1.5	1.3	3.1	3.2	3.3	3.3	0.5	23.3	0.6	2.4	3.4	2.3	4.8	9.5	5.7	4.1	0.0	1.6	1.7	4.0	2.7	6.5	5.5	1.9	3.5	1.8	3.6	0.8	3.9	1.3	6.4	1.5	7.3	4.2	8.6	7.3	1.4	5.1	9.2	6.0	4.1	8.8	2.0	0.2	14.7	4.1	3.2	3.3	6.7	3.7	3.3	3.1	4.4	2.9	3.5	3.6
PEX1	"ZWS, ZWS1"	ENSG00000127980	"Peroxisomal biogenesis factor 1"	O43933	7	92487020-92528531	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis, Protein transport, Transport"		"Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020235	Approved		Supported	Peroxisomes				Peroxisomes		"HPA020235: AB_1855224"	"unprognostic (4.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.35e-3)"	"unprognostic (4.90e-2)"	11.3	13.8	8.9	13.1	19.1	5.8	14.0	14.3	14.7	12.7	13.2	15.8	19.0	10.2	12.2	18.7	13.0	9.5	10.6	13.4	9.5	9.3	22.4	20.3	8.4	9.9	15.4	9.3	14.3	17.5	23.3	22.5	8.0	18.5	12.9	15.4	13.7	13.6	20.6	16.1	15.0	12.7	12.2	15.0	10.2	12.9	10.2	13.6	15.2	13.8	14.6	11.1	11.5	11.6	5.5	2.1	3.1	3.6	7.9	6.2	1.9	5.6	6.3	10.3	17.4	6.5	5.6	9.3	3.8	5.0	4.5	6.5	3.8	6.1	8.5	8.6	4.3	5.8	7.8	6.8	7.2	8.7	6.9	4.0	6.7	4.7	4.5	7.2	4.6	6.1	6.2	6.8	9.2	7.0	14.9	12.1	7.1	10.7	14.4	7.1	7.1	5.9	10.2	11.5	10.5	6.4	8.4	7.6	12.3	8.8	24.4	7.5	5.0	3.1	5.8	4.4	5.9	16.5	3.9	13.6	10.7	11.7	4.1	4.3	6.9	1.1	2.0	3.1	4.7	3.2	4.6	5.5	4.9	5.1	2.1	4.7	5.7	6.2	1.6	7.9	3.6	1.3	4.6	1.9	8.9	19.1	14.3	14.7	9.5	9.3	15.4	9.3	18.5	13.6
PEX14		ENSG00000142655	"Peroxisomal biogenesis factor 14"	O75381	1	10472288-10630758	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046104, HPA049231"	Supported		Supported	"Nucleoli fibrillar center,Peroxisomes"				Peroxisomes	"Nucleoli fibrillar center"	"HPA046104: , HPA049231: "	"unprognostic (7.23e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-3)"	"unprognostic (9.67e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.75e-2)"	14.9	11.6	14.3	12.2	22.3	8.3	13.1	15.7	35.0	11.8	14.8	18.6	8.3	18.0	14.4	10.4	22.6	14.8	12.2	17.8	14.4	16.2	13.3	25.9	13.6	11.6	13.0	16.1	15.7	15.3	13.6	14.2	17.7	22.4	21.9	10.5	14.8	20.0	31.0	22.1	14.6	20.9	10.7	11.1	11.2	12.8	18.7	11.4	11.4	13.5	11.6	17.3	38.7	13.6	4.2	5.0	7.3	3.8	4.2	8.4	3.6	15.4	14.6	12.5	13.7	9.2	8.7	8.1	17.9	15.1	20.0	19.1	15.4	28.9	11.3	18.0	13.7	18.6	13.0	17.3	9.6	15.8	21.2	13.9	15.9	21.1	13.9	15.6	20.0	10.5	14.0	15.1	14.0	12.8	21.7	11.7	9.0	12.8	14.9	20.6	12.8	17.2	16.2	10.4	16.2	15.8	10.3	14.9	17.0	17.3	14.5	16.1	13.3	11.2	12.3	14.7	15.5	14.1	15.2	16.8	13.6	22.1	16.1	21.7	15.6	1.9	3.8	7.3	8.4	2.8	5.3	4.2	4.4	6.2	4.7	3.9	5.8	5.2	0.6	4.2	2.5	5.0	5.2	3.6	14.3	22.3	15.7	35.0	14.4	16.2	13.0	16.1	22.4	11.4
PEX19	"D1S2223E, HK33, PMP1, PMPI, PXF, PXMP1"	ENSG00000162735	"Peroxisomal biogenesis factor 19"	P40855	1	160276812-160286348	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044837, HPA051966"	Supported		Supported	Peroxisomes				Peroxisomes		"HPA044837: AB_10962496, HPA051966: "	"unprognostic (1.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (2.92e-5)"	"unprognostic (3.46e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.24e-2)"	41.9	20.4	21.5	8.0	27.8	6.2	24.4	10.0	30.6	12.5	12.9	23.8	8.9	11.0	13.0	15.0	14.6	13.6	11.3	21.7	18.5	21.0	19.5	61.6	12.2	8.7	20.3	17.2	14.5	12.6	17.5	14.3	15.0	25.0	16.8	13.8	17.8	16.2	16.3	32.9	14.1	12.7	10.0	17.4	11.8	12.7	11.4	12.9	9.1	22.2	12.1	11.3	13.4	8.7	9.7	13.0	11.8	15.6	6.9	10.2	7.5	12.4	7.6	29.5	9.1	25.2	24.9	22.2	10.2	21.1	19.0	15.1	14.0	15.2	15.3	17.5	15.5	12.2	14.1	18.3	15.0	13.3	7.0	10.7	10.8	14.3	20.5	19.3	13.6	37.3	21.2	25.7	16.5	13.3	16.1	11.8	21.3	6.9	14.5	6.3	21.0	20.1	18.3	14.5	18.3	19.2	25.2	9.6	16.0	40.8	20.7	15.4	20.2	19.1	10.1	11.0	13.2	12.5	12.0	17.7	22.7	28.0	18.2	8.4	16.2	9.2	12.2	11.8	10.2	15.6	8.3	9.7	5.9	7.2	13.0	5.6	7.5	6.8	4.8	6.9	10.2	6.3	8.7	7.5	21.5	27.8	10.0	30.6	18.5	21.0	20.3	17.2	25.0	12.9
PEX3		ENSG00000034693	"Peroxisomal biogenesis factor 3"	P56589	6	143450807-143490010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042830, HPA058006"	Supported		Supported	Nucleoplasm,Peroxisomes				"Nucleoplasm, Peroxisomes"		"HPA042830: AB_10794918, HPA058006: AB_2683576"	"unprognostic (3.52e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"prognostic favourable (3.80e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.12e-1)"	10.1	47.5	13.7	14.0	15.5	3.3	14.5	17.3	17.7	13.6	8.5	12.1	14.0	7.0	12.5	16.4	21.1	12.5	9.0	15.8	14.3	11.4	22.7	29.2	9.6	10.3	13.7	15.9	14.4	8.6	16.2	14.8	22.2	17.4	15.0	8.1	10.4	12.8	15.7	12.6	14.6	8.8	12.7	14.6	8.7	11.3	14.4	12.7	10.1	19.3	13.5	11.6	11.9	15.1	18.2	8.7	7.8	9.6	12.0	18.7	8.1	14.4	3.6	7.6	16.0	12.7	12.5	9.6	13.0	10.6	18.0	22.0	23.4	9.4	25.4	15.5	13.9	12.3	10.5	18.4	22.3	14.7	12.9	17.9	7.3	15.0	11.7	28.9	7.3	15.2	12.6	17.3	13.0	9.9	15.2	11.7	17.2	10.2	14.6	11.7	4.9	13.0	11.2	17.2	10.9	22.1	6.3	11.8	4.2	17.3	15.0	11.5	7.5	9.6	9.0	12.9	11.1	22.0	15.4	8.4	10.6	25.4	16.9	20.0	10.1	7.8	5.1	4.9	13.2	8.0	15.1	18.2	14.1	13.1	7.9	15.4	18.7	17.9	0.8	12.0	9.6	8.7	16.5	8.1	13.7	15.5	17.3	17.7	14.3	11.4	13.7	15.9	17.4	12.7
PLIN1	PLIN	ENSG00000166819	"Perilipin 1"	O60240	15	89664365-89679427	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adipose tissue: 187.5;breast: 62.6"	"Cell line enriched"	"Detected in single"	176	"ASC diff: 68.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 8.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA024299, CAB033821, CAB037333"	Enhanced		Uncertain	Peroxisomes			8900	Peroxisomes		"CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467"	"unprognostic (4.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.62e-6)"	"unprognostic (5.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.85e-2)"	187.5	2.6	1.8	7.1	1.3	0.3	62.6	0.8	0.8	0.3	10.6	1.6	0.4	0.4	0.3	1.9	0.5	0.4	7.4	8.3	2.7	0.6	0.6	5.8	0.3	2.8	0.8	1.5	0.4	1.4	0.3	0.1	0.3	1.0	0.4	1.1	0.0	7.6	1.5	7.2	2.2	2.2	0.6	0.4	0.3	0.5	1.6	1.8	0.0	0.7	8.0	0.3	1.5	1.5	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	68.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.8	1.3	0.8	0.7	2.7	0.6	0.8	1.5	1.0	1.8
PRRT4		ENSG00000224940	"Proline rich transmembrane protein 4"	C9JH25	7	128350325-128361685	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 49.0"	"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 70.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA046373, HPA052681"	Uncertain		Approved	"Nucleoplasm,Peroxisomes,Plasma membrane"	"Intracellular and membrane"			Nucleoplasm	"Peroxisomes, Plasma membrane"	"HPA046373: , HPA052681: "	"unprognostic (1.72e-1)"	"unprognostic (4.55e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.20e-4)"	"unprognostic (2.60e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.73e-4)"	"unprognostic (5.28e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.27e-2)"	12.1	1.9	2.0	5.9	11.3	49.0	6.8	6.5	3.1	1.6	2.7	0.6	0.0	0.6	0.7	0.5	1.9	1.0	1.1	2.4	1.7	6.2	0.5	0.7	0.8	0.6	1.6	2.4	1.0	0.6	0.8	0.0	0.6	2.9	0.8	0.7	3.4	1.9	1.3	4.2	1.5	0.8	1.0	2.8	1.3	1.6	0.7	1.5	0.7	0.7	1.7	1.0	2.0	3.2	0.0	0.4	0.4	0.4	0.0	1.5	0.4	0.0	0.0	0.1	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	13.8	0.3	0.0	3.8	0.2	0.3	0.0	0.0	0.1	70.3	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.2	0.5	0.0	0.0	1.5	0.7	0.4	0.0	0.0	0.4	0.0	0.4	2.0	11.3	6.5	3.1	1.7	6.2	1.6	2.4	2.9	1.5
PXMP4	PMP24	ENSG00000101417	"Peroxisomal membrane protein 4"	Q9Y6I8	20	33702754-33720319	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.3;SK-BR-3: 35.3;T-47d: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050077	Approved		Approved	"Nucleoli fibrillar center,Peroxisomes"				Peroxisomes	"Nucleoli fibrillar center"	"HPA050077: "	"unprognostic (3.41e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-1)"	"prognostic favourable (3.88e-4)"	"unprognostic (3.53e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.86e-1)"	"prognostic favourable (4.03e-10)"	"unprognostic (3.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.20e-1)"	6.2	20.0	6.4	5.4	10.0	3.9	15.6	4.7	12.6	7.8	7.8	12.5	16.9	10.1	7.1	7.1	10.0	8.0	9.1	7.9	6.7	5.3	6.7	13.4	27.5	9.3	6.1	9.2	9.2	9.5	24.4	5.3	5.0	6.5	11.5	7.5	10.8	27.6	13.2	9.9	14.4	11.8	7.1	7.6	6.4	9.0	4.2	5.9	8.4	19.0	6.9	5.9	10.6	9.0	6.2	6.2	12.0	21.9	5.8	8.5	5.5	1.2	5.5	1.5	5.5	2.7	4.0	4.0	4.0	2.2	3.1	1.3	19.3	6.1	0.0	7.6	3.3	5.8	4.2	4.6	2.2	1.6	1.5	6.3	4.7	0.1	2.5	0.3	4.8	3.0	5.1	4.2	1.4	2.0	3.5	4.0	2.2	11.8	5.7	4.4	0.2	0.0	3.0	7.6	0.7	1.9	4.1	5.0	2.5	11.1	35.3	3.5	29.8	2.1	3.9	2.2	2.5	5.6	3.7	2.6	5.7	0.1	4.3	2.1	3.7	1.4	8.0	12.0	8.1	14.9	8.5	5.5	8.3	8.1	6.2	6.2	6.3	8.5	2.1	5.8	21.9	3.8	5.7	5.5	6.4	10.0	4.7	12.6	6.7	5.3	6.1	9.2	6.5	5.9
SCP2		ENSG00000116171	"Sterol carrier protein 2"	P22307	1	52927229-53051703	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 168.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027101, HPA027135, HPA027317"	Supported		Supported	Peroxisomes			370000	Peroxisomes		"HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422"	"unprognostic (7.51e-2)"	"unprognostic (5.23e-2)"	"prognostic favourable (7.05e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.53e-2)"	"unprognostic (6.16e-2)"	"prognostic favourable (7.85e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-2)"	29.1	26.2	21.8	19.9	21.2	14.0	30.3	12.0	19.7	24.4	51.9	15.9	28.1	49.2	19.0	28.8	32.2	18.1	32.1	29.3	20.0	20.0	54.2	168.3	21.8	14.0	25.6	17.8	22.8	24.6	16.7	24.1	17.1	21.9	25.5	40.5	18.9	21.8	23.3	22.0	18.8	80.1	20.6	27.1	20.9	33.9	16.7	19.4	23.0	28.2	28.6	17.6	22.3	20.5	36.4	57.1	67.8	50.7	40.8	49.2	61.2	25.9	14.3	19.3	35.3	63.3	54.1	20.9	31.0	46.6	20.4	29.6	12.8	28.2	24.7	33.6	45.4	18.3	13.2	29.0	31.2	36.0	19.2	26.6	20.5	26.3	42.2	38.3	44.9	43.9	39.6	24.2	12.1	57.7	23.6	12.9	41.2	15.0	42.5	33.3	21.1	28.1	22.4	33.9	33.8	56.5	44.2	16.0	19.2	27.1	55.0	25.9	28.1	43.8	44.6	27.8	14.4	48.4	24.7	21.6	27.4	28.9	36.0	38.1	25.7	55.4	48.7	67.8	49.2	50.7	39.9	36.4	39.2	48.6	57.1	29.8	33.2	47.1	7.5	40.8	46.8	37.1	47.1	61.2	21.8	21.2	12.0	19.7	20.0	20.0	25.6	17.8	21.9	19.4
SLC25A17	PMP34	ENSG00000100372	"Solute carrier family 25 member 17"	O43808	22	40769630-40819399	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052708, HPA060972"	Approved		Supported	Peroxisomes				Peroxisomes		"HPA052708: , HPA060972: "	"unprognostic (2.75e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.91e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	9.7	15.0	10.2	10.2	10.9	3.3	16.8	12.9	14.1	11.8	7.2	12.2	7.5	6.4	22.4	22.6	8.7	13.7	7.4	5.5	10.4	13.4	18.6	19.7	9.0	11.8	10.3	7.7	26.5	12.4	14.3	13.0	14.9	11.9	12.6	8.7	9.5	11.4	10.3	4.6	10.9	7.1	12.1	11.4	8.8	8.9	12.1	9.5	12.6	14.7	10.4	11.2	7.1	8.7	10.2	6.8	5.9	4.9	10.3	11.7	6.4	13.2	7.3	12.4	10.8	7.9	9.5	10.1	12.1	13.2	19.2	21.2	10.6	5.0	15.7	7.4	11.8	10.6	18.0	9.9	19.7	16.1	24.2	17.6	11.4	11.0	11.1	20.2	9.4	9.5	13.3	17.0	10.9	11.7	25.3	7.5	15.6	11.4	12.2	13.1	10.5	12.1	13.3	19.3	22.8	15.8	11.3	8.6	7.8	24.8	15.3	14.7	12.7	6.0	6.8	10.8	14.8	9.6	10.9	8.3	16.1	14.9	11.8	10.2	11.8	5.9	4.4	5.1	7.0	4.9	9.2	10.2	8.1	7.5	5.7	9.5	11.7	9.3	1.8	10.3	3.9	6.8	10.8	6.4	10.2	10.9	12.9	14.1	10.4	13.4	10.3	7.7	11.9	9.5
TMEM41B	KIAA0033	ENSG00000166471	"Transmembrane protein 41B"	Q5BJD5	11	9280654-9314780	"Predicted membrane proteins"	"Autophagy, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014946	Uncertain		Approved	Peroxisomes				Peroxisomes		"HPA014946: AB_2205037"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (9.18e-6)"	"unprognostic (6.18e-2)"	"unprognostic (9.37e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.55e-2)"	"unprognostic (8.18e-2)"	9.2	11.6	11.9	8.7	13.0	15.5	10.5	13.7	17.6	8.0	14.3	20.1	15.6	21.8	7.3	10.6	13.5	7.8	10.5	10.7	11.9	14.6	14.6	23.0	19.3	9.5	16.2	12.9	9.1	14.6	18.8	13.4	13.8	20.1	14.0	11.3	10.1	11.8	11.1	8.8	15.9	21.2	5.9	13.5	10.2	15.5	14.9	14.6	14.9	21.3	8.5	11.0	9.6	8.8	7.2	6.0	8.0	2.4	7.1	9.2	3.7	12.8	13.5	7.6	6.5	7.5	10.9	18.3	11.5	11.0	6.8	12.6	6.4	41.9	5.6	10.8	7.3	16.9	8.8	7.0	8.5	9.6	6.8	4.6	9.1	6.6	9.7	4.1	6.4	9.2	9.9	6.5	8.2	5.8	9.7	14.1	13.2	4.6	6.7	1.8	23.5	7.1	4.5	10.6	7.7	10.6	13.0	2.4	8.4	11.5	9.7	8.0	8.6	6.5	8.0	7.6	8.8	11.7	6.0	4.5	7.0	10.1	8.5	2.6	6.2	6.3	1.9	7.4	4.7	1.6	4.3	7.2	4.4	5.1	3.1	5.9	9.2	7.6	8.0	7.1	2.4	6.0	4.0	3.7	11.9	13.0	13.7	17.6	11.9	14.6	16.2	12.9	20.1	14.6